Your browser doesn't support javascript.
loading
Effectiveness of acyclovir in the treatment of pityriasis rosea. A systematic review and meta-analysis
Rodriguez-Zuniga, Milton; Torres, Natalie; Garcia-Perdomo, Herney.
  • Rodriguez-Zuniga, Milton; Universidad Nacional Mayor de San Marcos. Hospital Nacional Daniel Alcides Carrion. Dermatology Department. Lima. PE
  • Torres, Natalie; Universidad Nacional Mayor de San Marcos. Hospital Nacional Dos de Mayo. Dermatology Department. Lima. PE
  • Garcia-Perdomo, Herney; Universidad del Valle. Postgraduate Clinical Programs. Cali. CO
An. bras. dermatol ; 93(5): 686-695, Sept.-Oct. 2018. tab, graf
Article in English | LILACS | ID: biblio-949961
ABSTRACT
Abstract

Background:

There is a lack of evidence to support acyclovir administration in pityriasis rosea.

Objective:

To determine the efficacy of acyclovir in patients with typical pityriasis rosea.

Methods:

A systematic review and meta-analysis of experimental studies was performed in MEDLINE, SCOPUS, EMBASE and others, from January 1990 to October 2016 on acyclovir for pityriasis rosea. Random effect model was used to find the pooled Risk Ratio. Outcomes, evaluated between weeks 1 to 8, were regression of lesions, cessation of lesions, decrease of symptoms and duration of disease. Comparisons were acyclovir vs. placebo; acyclovir vs. symptomatic treatment; acyclovir vs. antibiotic; acyclovir vs. observation and combined therapy (acyclovir plus symptomatic treatment) vs. symptomatic treatment alone.

Results:

Seven papers were analyzed with 324 participants, of which 159 received acyclovir and 165 were controls. Acyclovir was superior to placebo for complete regression of lesions at week 1 (Risk Ratio 5.72, CI95% 2.36-13.88). However, combined therapy was not superior to symptomatic treatment at week 4 (Risk Ratio 1.46, CI95% 0.93-2.29). Individual studies showed the superiority of acyclovir for the control of symptoms and pruritus. Study

limitations:

We faced differences designs of trials and inconsistency between reports.

Conclusion:

Symptomatic treatment is a reasonable option for pityriasis rosea, and the addition of acyclovir is justified for the control of symptoms and pruritus.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Antiviral Agents / Acyclovir / Pityriasis Rosea Type of study: Controlled clinical trial / Observational study / Prognostic study / Risk factors / Systematic reviews Limits: Adult / Child / Female / Humans / Male Language: English Journal: An. bras. dermatol Journal subject: Dermatology Year: 2018 Type: Article Affiliation country: Colombia / Peru Institution/Affiliation country: Universidad Nacional Mayor de San Marcos/PE / Universidad del Valle/CO

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Antiviral Agents / Acyclovir / Pityriasis Rosea Type of study: Controlled clinical trial / Observational study / Prognostic study / Risk factors / Systematic reviews Limits: Adult / Child / Female / Humans / Male Language: English Journal: An. bras. dermatol Journal subject: Dermatology Year: 2018 Type: Article Affiliation country: Colombia / Peru Institution/Affiliation country: Universidad Nacional Mayor de San Marcos/PE / Universidad del Valle/CO